macra

CMS Promotes COVID-19 Clinical Trials Improvement Activity in Letter to Clinicians

April 29, 2020

McDermott+Consulting

In a letter to clinicians, the Centers for Medicare & Medicaid Services (CMS) encouraged clinicians who participate in the Quality Payment Program (QPP) to contribute to scientific research and evidence through clinical trials to help fight the COVID-19 pandemic. Clinicians who participate in a clinical trial and report their findings to a clinical data repository or registry can earn credit in the Merit-based Incentive Payment System (MIPS) for the 2020 Performance Period by attesting to the new COVID-19 Clinical Trials improvement activity.

MIPS is comprised of four performance categories that contribute to a clinician’s overall final score each year. The MIPS Improvement Activities performance category is worth 15% of the overall MIPS final score.

 

______________________________________________________________________________

For more information visit the McDermottPlus Payment Innovation Resource Center or contact Sheila Madhani at 202-204-1459 or smadhani@mcdermottplus.com.

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope